Thanks for the info Teddy.
No CEO and no COO. Not a good look.
Would have thought that the COO leaving was worth a mention by the company. They did annouce her appointment in the annoucement of 12th July.
Worked at POH, 6 months. May - October 2013.
Joined right at the time of Esragate. Nice welcome and introduction to the company! Maybe had the result of her not being comfortable in the position and finally resigned. And right in the middle of the Oxymorphone trial. Now releasing that information to public during the trial would have caused a tail spin.
Things at POH seem to be on the up. So why leave when the company "appears" to have turned a corner.
The more things change, the more they stay the same!
new ceo and board 'business model', page-27
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.32K | 440K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 40522233 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 40065430 | 31 |
View Market Depth
| Last trade - 14.05pm 15/11/2024 (20 minute delay) ? |
| AVE (ASX) Chart |